Chemotherapy for Castration Resistant Metastatic Prostate Cancer

@inproceedings{Hervonen2014ChemotherapyFC,
  title={Chemotherapy for Castration Resistant Metastatic Prostate Cancer},
  author={Petteri Hervonen},
  year={2014}
}

Tables and Topics from this paper.

References

Publications referenced by this paper.
SHOWING 1-10 OF 116 REFERENCES

Randomized, open-label phase III trial of docetaxel plus high-dose calcitriol versus docetaxel plus prednisone for patients with castration-resistant prostate cancer.

  • Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • 2011
VIEW 3 EXCERPTS
HIGHLY INFLUENTIAL

Sipuleucel-T immunotherapy for castration-resistant prostate cancer.

  • The New England journal of medicine
  • 2010
VIEW 8 EXCERPTS
HIGHLY INFLUENTIAL

NORDCAN. Cancer Incidence, Mortality, Prevalence and Survival in the Nordic Countries, Version

G Engholm, J Ferlay, +3 authors JE Køtlum
  • Danish Cancer Society. Available from http://www.ancr.nu,
  • 2013
VIEW 3 EXCERPTS
HIGHLY INFLUENTIAL

Similar Papers

Loading similar papers…